Cerclage-CRT: The Effect of "Cerclage Pacing" for the Heart Failure Patients Who Need Cardiac Resynchronization Therapy (CRT)

Sponsor
Tau Pnu Medical Co., Ltd. (Industry)
Overall Status
Completed
CT.gov ID
NCT03438591
Collaborator
(none)
2
1
1
15.8
0.1

Study Details

Study Description

Brief Summary

trans-coronary sinus intraseptal pacing (cerclage pacing)

Condition or Disease Intervention/Treatment Phase
  • Device: Medtronic 4196 lead
N/A

Detailed Description

This study is aimed at looking at the effect of "Cerclage pacing" for the heart failure patients who need cardiac resynchronization therapy (CRT). The study hypothesis is that parahisian pacing by 'cerclage pacing' may have a similar benefit as is seen with permanent Hisian pacing

Study Design

Study Type:
Interventional
Actual Enrollment :
2 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
patients who meet the criteria of current CRT treatmentpatients who meet the criteria of current CRT treatment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of "Cerclage Pacing" for the Heart Failure Patients Who Need Cardiac Resynchronization Therapy (CRT): Early Feasibility Study
Actual Study Start Date :
Mar 5, 2018
Actual Primary Completion Date :
Mar 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cerclage-CRT (medtronic 4196 lead)

trans-coronary sinus intraseptal pacing (cerclage pacing) which technology to position the pacemaker lead into the septum for 'parahisian pacing'

Device: Medtronic 4196 lead
Cerclage-CRT pacing with Medtronic 4196 lead (Attain Ability Lead)

Outcome Measures

Primary Outcome Measures

  1. rate of procedural success [immediate postprocedure]

    Narrowing QRS by 20% or greater compared with baseline QRS width

Secondary Outcome Measures

  1. Change in subjects' symptoms referred to NYHA Classification System [12 months]

    NYHA (New York Heart Association) : +1 grade

  2. Change in subjects' improvement of parameters by Echocardiography [12 months]

    Ejection Fraction +5%

  3. Change of Six minute walk Distance [12 months]

    improvement of SMWD

  4. interrogation index of pacemaker lead [12 months]

    interrogation index of pacemaker lead

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • who need cardiac resynchronization therapy (CRT) or CRT-non responder

  • Left bundle branch block [LBBB]) > 120ms of QRS width

  • Ejection fraction (EF) < 35%

  • NYHA class III-IV in spite of optimal medical Tx

Exclusion Criteria:
  • Unsuitable coronary vein anatomy on cardiac CT

  • Subjects with prosthetic mechanical tricuspid valve

  • Active infection

  • Life expectancy less than 6 months

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pusan National University Yangsan Hospital Yangsan Gyeongsangnamdo Korea, Republic of 50602

Sponsors and Collaborators

  • Tau Pnu Medical Co., Ltd.

Investigators

  • Principal Investigator: June-Hong Kim, MD, PhD, Pusan National University Yangsan Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
June-Hong Kim, MD, PhD, Professor, Pusan National University Yangsan Hospital
ClinicalTrials.gov Identifier:
NCT03438591
Other Study ID Numbers:
  • Cerclage-CRT
First Posted:
Feb 19, 2018
Last Update Posted:
Sep 11, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by June-Hong Kim, MD, PhD, Professor, Pusan National University Yangsan Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 11, 2019